Quarterly report pursuant to Section 13 or 15(d)

Cover Page

Cover Page - shares
3 Months Ended
Feb. 28, 2022
Apr. 13, 2022
Cover [Abstract]    
Document Type 10-Q/A  
Amendment Flag true  
Document Period End Date Feb. 28, 2022  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q1  
Current Fiscal Year End Date --11-30  
Entity Interactive Data Current Yes  
Entity Current Reporting Status Yes  
Trading Symbol CCEL  
Entity Central Index Key 0000862692  
Entity Registrant Name CRYO-CELL INTERNATIONAL, INC.  
Entity Shell Company false  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity File Number 001-40767  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 22-3023093  
Entity Address, Address Line One 700 Brooker Creek Blvd  
Entity Address, City or Town Oldsmar  
Entity Address, State or Province FL  
Entity Address, Postal Zip Code 34677  
City Area Code 813  
Local Phone Number 749-2100  
Document Quarterly Report true  
Document Transition Report false  
Title of 12(b) Security Common Stock, $0.01 par value  
Entity Common Stock, Shares Outstanding   8,460,380
Security Exchange Name NASDAQ  
Amendment Description Explanatory Note  This Amendment No. 1 (the “Amendment”) to the Quarterly Report on Form10-Q of Cryo-Cell International, Inc. (the “Company”) for the first quarter ended February 28, 2022, originally filed with the Securities and Exchange Commission on April 13, 2022 (the “Original Form10-Q”), is being filed solely to correct an error in the third paragraph of Note 14 (Subsequent Events) to the Company’s financial statements contained therein. Such third paragraph is replaced with the following:On April 4, 2022, the Company filed a Registration Statement on Form S-1 with the Securities and Exchange Commission for a public offering of senior promissory notes. The proposed maximum aggregate offering is $20,000,000 (exclusive of the underwriter's overallotment option). The Form S-1 has not yet been declared effective by the Securities and Exchange Commission. The Company can provide no assurance that it will consummate an offering under the Form S-1. The foregoing does not constitute an offer of any securities for sale.  This Amendment should be read in conjunction with the Original Form 10-Q, is limited in scope to the correction described above and does not amend, update, or change any other items or disclosures contained in the Original Form 10-Q. Accordingly, all other items that remain unaffected are omitted in this filing. Except as described in the preceding paragraph, this Amendment does not update any of the information contained in the Original Form 10-Q, which continues to speak as of the original filing date of the Original Form 10-Q.